Publisher： Bentham Science Publishers
E-ISSN： 1873-5592|17|6|739-745
ISSN： 1389-4501
Source： Current Drug Targets, Vol.17, Iss.6, 2016-05, pp. : 739-745
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Type III or allosteric kinase inhibitors for the treatment of non-small cell lung cancer
By Fasano Morena Della Corte Carminia Maria Califano Raffaele Capuano Annalisa Troiani Teresa Martinelli Erika Ciardiello Fortunato Morgillo Floriana
Expert Opinion on Investigational Drugs, Vol. 23, Iss. 6, 2014-06 ,pp. :
By Nguewa Paul A Calvo Alfonso Pullamsetti Soni Savai Banat Gamal Andre Grimminger Friedrich Savai Rajkumar
Expert Opinion on Investigational Drugs, Vol. 20, Iss. 1, 2011-01 ,pp. :
Epidermal Growth Factor Receptor Inhibitors in Non-Small Cell Lung Cancer
Drugs, Vol. 67, Iss. 8, 2007-01 ,pp. :